Harriet Fear, One Nucleus: maximising member benefits and global competitiveness




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Harriet Fear, One Nucleus: maximising member benefits and global competitiveness
Released on: September 17, 2015. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Harriet Fear, CEO of One Nucleus talks to Adrian Dawkes of PharmaVentures about their annual event ON Helix, which focuses on Translational Research, and compliments their more industry focused annual event called Genesis.
  • Summary
  • Transcript
  • Participants
  • Company
Harriet Fear, CEO of One Nucleus talks to Adrian Dawkes of PharmaVentures about their annual event ON Helix, which focuses on Translational Research, and compliments their more industry focused annual event called Genesis. One Nucleus is a not-for-profit organisation, which has its largest foot print of members in the Cambridge and London “corridor”, which is the largest healthcare biocluster in Europe. One Nucleus is as a leading European Healthcare Network that helps maximise the global competitiveness of their members through group purchasing initiatives, events, training and other support. Harriet talks about their growing international membership, and their focus on developing international collaborations with other leading membership organisations such as MassBIO, BIOCOM and BayBIO.
Harriet Fear, CEO of One Nucleus talks to Adrian Dawkes of PharmaVentures about their annual event ON Helix, which focuses on Translational Research, and compliments their more industry focused annual event called Genesis. One Nucleus is a not-for-profit organisation, which has its largest foot print of members in the Cambridge and London “corridor”, which is the largest healthcare biocluster in Europe. One Nucleus is as a leading European Healthcare Network that helps maximise the global competitiveness of their members through group purchasing initiatives, events, training and other support. Harriet talks about their growing international membership, and their focus on developing international collaborations with other leading membership organisations such as MassBIO, BIOCOM and BayBIO.
Harriet Fear, CEO, One Nucleus
Harriet Fear, CEO of One Nucleus talks to Adrian Dawkes of PharmaVentures about their annual event ON Helix, which focuses on Translational Research, and compliments their more industry focused annual event called Genesis. One Nucleus is a not-for-profit organisation, which has its largest foot print of members in the Cambridge and London “corridor”, which is the largest healthcare biocluster in Europe. One Nucleus is as a leading European Healthcare Network that helps maximise the global competitiveness of their members through group purchasing initiatives, events, training and other support. Harriet talks about their growing international membership, and their focus on developing international collaborations with other leading membership organisations such as MassBIO, BIOCOM and BayBIO.